The DOI matches its Crossref record.
Nonreversible airflow obstruction in life‐long nonsmokers with moderate to severe asthma
Open accessAbstract
The aim of this longitudinal study was to assess the frequency of nonreversible airflow obstruction (NRAO) among adults with moderate to severe asthma, and to compare the decline of forced expiratory volume in one second (FEV1) in asthmatics with reversible and nonreversible airflow obstruction. Ninety-two (31 males) life-long nonsmokers with asthma participated in a 10-yr follow-up study; mean age 37 yrs (range 18-64) and duration of asthma 16 yrs (range 2-60) at enrolment. Case history, including use of asthma medication, was obtained, and pulmonary function, including diffusion capacity, was measured using standard techniques. At enrolment, all patients had typical symptoms and reversible airflow obstruction. (NRAO) was defined as FEV1 <80% predicted and change in deltaFEV1 after 5 mg salbutamol <9% pred. A total of 21 (23%) patients (mean age at enrolment 32 yrs) fulfilled the criteria for NRAO at the time of follow-up; current therapy was inhaled steroids (n=21, mean daily dose 1.5 mg), oral steroids (n=14), theophylline (n=20), oral beta2-agonist (n=6) and inhaled beta2-agonist. The patients with NRAO (n=21) had a steeper decline in FEV1 than the remaining patients (n=71, reversible airflow obstruction (RAO)), mean+/-SD 53+/-23 mL x yr(-1) and 36+/-21 mL x yr(-1), respectively (p<0.003). Increasing degree of bronchodilator reversibility (deltaFEV1% pred) at enrolment (p=0.002) and long-term treatment with oral corticosteroids (p=0.009) were associated with an increased risk for the presence of NRAO at follow-up. The comparison of data for NRAO and RAO patients (at follow-up) revealed no significant differences in mean values for total diffusion capacity (TL,CO), diffusion constant (KCO), or total lung capacity. The findings suggest that a subgroup of asthmatics may experience very steep rates of decline in forced expiratory volume in one second leading to severe nonreversible airflow obstruction, whereas no indication was found that long-standing asthma may lead to the development of emphysema.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chronic Obstructive Pulmonary Disease Surveillance—United States, 1971–2000
Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S., & Redd, S. C. (2002) · Respiratory Care · doi:10.1177/002013240204701009 · Cited by 1,294
Eisner, M. D., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E. K., & Balmes, J. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1757st · Cited by 978
Mannino, D. M. (2002) · Chest · doi:10.1378/chest.121.5_suppl.121s · Cited by 576
Decline in Lung Function in the Busselton Health Study
James, A. L., Palmer, L. J., Kicic, E., Maxwell, P. S., Lagan, S. E., Ryan, G. F., & Musk, A. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-230oc · Cited by 397
Severe exacerbations predict excess lung function decline in asthma
Bai, T. R., Vonk, J. M., Postma, D. S., & Boezen, H. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00165106 · Cited by 385
Metadata
- Authors
- Ulrik, C. S., & Backer, V.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 1999-10
- Volume
- 14
- Issue
- 4
- Pages
- 892
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2103853238
- Cited by
- 174
- References
- 0
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nonreversible airflow obstruction in life‐long nonsmokers with moderate to severe asthma. https://app.cochat.ai/papers/10.1034/j.1399-3003.1999.14d27.x
- The paper
- Ulrik, C. S., & Backer, V. (1999). Nonreversible airflow obstruction in life‐long nonsmokers with moderate to severe asthma. European Respiratory Journal. https://doi.org/10.1034/j.1399-3003.1999.14d27.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.